高血压病理生理学的性别特异性差异
Hannah Zhang1,2, Pawan K Singal1,2, Amir Ravandi1,2,3
1Department of Physiology and Pathophysiology, St. Boniface Hospital Albrechtsen Research Centre, Institute of Cardiovascular Sciences, Rady College of Medicine, Max Rady Faculty of Health Sciences, University of Manitoba, Rm. 3042, 351 Taché Avenue, Winnipeg, MB R2H 2A6, Canada.
Biomolecules
|January 25, 2025
概括
性激素通过改变脂肪代谢来影响高血压. 雌激素促进更健康的脂肪储存,降低绝经前妇女的高血压风险,而雌激素和低雌激素促进内脏脂肪,增加男性和绝经后妇女的风险.
科学领域:
- 心血管生理学心血管生理学
- 内分泌学 在内分泌学.
- 代谢疾病研究研究
背景情况:
- 高血压是心脏代谢疾病中常见的并发症,影响了近三分之一的成年人.
- 已确定的机制包括压力性水,氨酸-血管素系统 (RAS),交感神经系统活动,氧化应激和内皮功能障碍.
- 高血压发展存在显著的基于性别的差异,但潜在的病理生理机制仍然不完全理解.
研究的目的:
- 审查和假定性二形脂肪代谢在高血压生理学的作用.
- 阐明性激素,特别是雌激素和雄激素如何影响脂肪组织分布和功能,与高血压有关.
- 突出高血压管理的潜在的性别特异性治疗点.
主要方法:
- 这是一篇综述性文章,综合了有关高血压,性激素和脂肪代谢的现有文献.
- 该综述侧重于雌激素和雄激素对脂肪组织沉积 (皮下与内脏) 和功能的对比作用.
- 讨论了将脂肪代谢与高血压联系起来的病理生理途径,包括炎症和RAS激活.
主要成果:
- 雌激素促进皮下脂肪沉积和自适应性激增,导致抗炎作用,抑制代谢功能障碍相关的脂肪肝疾病 (MAFLD),并减少RAS激活,有助于降低绝经前女性的高血压率.
- 雄激素和雌激素缺乏促进内脏和宫外脂肪沉积 (包括肝脏),增加促炎性细胞因子,并可能激活RAS,从而导致男性和绝经后女性高血压的发展.
- 性二形脂肪代谢是高血压病原发生的关键因素,但尚未得到充分研究.
结论:
- 由性激素驱动的脂肪代谢的性别特异性差异显著导致男性和女性之间高血压的不同患病率和机制.
- 针对性别特定的脂肪代谢途径可能为个性化高血压预防和治疗提供新的策略.
- 对这些性别特异性机制的进一步研究对于开发全面,量身定制的心血管保健至关重要.
相关概念视频
Hypertension and Regulation of Blood Pressure
1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Disorders of the Autonomic Nervous System
526
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
526
Hormonal Regulation of Blood Pressure
2.4K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.4K
Factors affecting Blood pressure
2.9K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
2.9K
Antihypertensive Drugs: Action of β1 Blockers
305
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
305
Antihypertensive Drugs: Vasodilators
464
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
464


